Literature DB >> 11083663

Susceptibilities of Corynebacterium bovis and Corynebacterium amylocolatum isolates from bovine mammary glands to 15 antimicrobial agents.

J L Watts1, S Rossbach.   

Abstract

Coryneform bacteria are frequently isolated from bovine mastitis and are associated with economic losses. Generally, the MICs of the 15 antimicrobial agents tested at which 90% of the isolates tested are inhibited for 46 Corynebacterium bovis and 13 Corynebacterium amylocolatum strains were low. These are the first quantitative antimicrobial susceptibility data available for coryneforms from bovine mastitis. Data from this study suggest that comparable corynebacteria from humans have a much higher level of antimicrobial resistance to a variety of antimicrobial agents.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11083663      PMCID: PMC90228          DOI: 10.1128/AAC.44.12.3476-3477.2000

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  7 in total

1.  In vitro activity of premafloxacin, a new extended-spectrum fluoroquinolone, against pathogens of veterinary importance.

Authors:  J L Watts; S A Salmon; M S Sanchez; R J Yancey
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

2.  Identification of corynebacterium bovis and other coryneforms isolated from bovine mammary glands.

Authors:  J L Watts; D E Lowery; J F Teel; S Rossbach
Journal:  J Dairy Sci       Date:  2000-10       Impact factor: 4.034

Review 3.  Clinical microbiology of coryneform bacteria.

Authors:  G Funke; A von Graevenitz; J E Clarridge; K A Bernard
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

4.  Antimicrobial susceptibility patterns of some recently established coryneform bacteria.

Authors:  G Funke; V Pünter; A von Graevenitz
Journal:  Antimicrob Agents Chemother       Date:  1996-12       Impact factor: 5.191

5.  The susceptibility of bovine udder quarters colonized with Corynebacterium bovis to experimental infection with Staphylococcus aureus or Streptococcus agalactiae.

Authors:  B W Brooks; D A Barnum
Journal:  Can J Comp Med       Date:  1984-04

6.  Antimicrobial susceptibilities of Corynebacterium species and other non-spore-forming gram-positive bacilli to 18 antimicrobial agents.

Authors:  F Soriano; J Zapardiel; E Nieto
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

7.  Effects of Corynebacterium bovis infection on susceptibility to major mastitis pathogens.

Authors:  J W Pankey; S C Nickerson; R L Boddie; J S Hogan
Journal:  J Dairy Sci       Date:  1985-10       Impact factor: 4.034

  7 in total
  6 in total

1.  Strategies to prevent, treat, and provoke Corynebacterium-associated hyperkeratosis in athymic nude mice.

Authors:  Holly N Burr; Neil S Lipman; Julie R White; Junting Zheng; Felix R Wolf
Journal:  J Am Assoc Lab Anim Sci       Date:  2011-05       Impact factor: 1.232

2.  Metaphylactic Antibiotic Treatment to Prevent the Transmission of Corynebacterium bovis to Immunocompromised Mouse Offspring.

Authors:  Emily C Pearson; Umarani Pugazhenthi; Derek L Fong; Derek E Smith; Andrew G Nicklawsky; Lauren M Habenicht; Michael K Fink; Jori K Leszczynski; Michael J Schurr; Christopher A Manuel
Journal:  J Am Assoc Lab Anim Sci       Date:  2020-09-09       Impact factor: 1.232

3.  Antimicrobial Susceptibility of Corynebacterium bovis Isolates from Immunodeficient Rodents.

Authors:  Anna C Fagre; Uma Pugazhenthi; Christopher Cheleuitte-Nieves; Marcus J Crim; Kenneth S Henderson; Derek L Fong; Jori K Leszczynski; Michael J Schurr; Joshua B Daniels; Christopher A Manuel
Journal:  Comp Med       Date:  2021-04-08       Impact factor: 0.982

4.  The Brief Case: Ventilator-Associated Corynebacterium accolens Pneumonia in a Patient with Respiratory Failure Due to COVID-19.

Authors:  Benjamin M Liu; Emily M Beck; Mark A Fisher
Journal:  J Clin Microbiol       Date:  2021-08-18       Impact factor: 5.948

5.  Effect of Antimicrobial Prophylaxis on Corynebacterium bovis Infection and the Skin Microbiome of Immunodeficient Mice.

Authors:  Christopher A Manuel; Linda K Johnson; Uma Pugazhenthi; Derek L Fong; Michaelk Fink; Lauren M Habenicht; Jori K Leszczynski; I R Diana; Michael J Schurr; Daniel N Frank
Journal:  Comp Med       Date:  2022-04-04       Impact factor: 1.565

6.  Isolation and characterization of Corynebacterium spp. from bulk tank raw cow's milk of different dairy farms in Germany.

Authors:  Julia Hahne; Tabea Kloster; Sandra Rathmann; Mareike Weber; André Lipski
Journal:  PLoS One       Date:  2018-04-04       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.